4 article(s) from Langer, Klaus
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
- Sebastian Pieper,
- Hannah Onafuye,
- Dennis Mulac,
- Jindrich Cinatl Jr.,
- Mark N. Wass,
- Martin Michaelis and
- Klaus Langer
Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
- Hannah Onafuye,
- Sebastian Pieper,
- Dennis Mulac,
- Jindrich Cinatl Jr.,
- Mark N. Wass,
- Klaus Langer and
- Martin Michaelis
Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166
Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles
- Katrin Partikel,
- Robin Korte,
- Dennis Mulac,
- Hans-Ulrich Humpf and
- Klaus Langer
Beilstein J. Nanotechnol. 2019, 10, 1002–1015, doi:10.3762/bjnano.10.101
pH-Triggered release from surface-modified poly(lactic-co-glycolic acid) nanoparticles
- Manuel Häuser,
- Klaus Langer and
- Monika Schönhoff
Beilstein J. Nanotechnol. 2015, 6, 2504–2512, doi:10.3762/bjnano.6.260
Other Beilstein-Institut Open Science Activities
